Zennova Pharmaceuticals Group announced that it has received nearly CNY 100 million in a round of funding on July 21, 2023. The transaction included participation from new investor Hengbao Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 CNY | -1.54% |
|
+1.39% | -33.59% |
May. 31 | Hengbao Co.,Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 30 | Hengbao Co.,Ltd. Proposes Final Dividend for 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.59% | 495M | |
+159.36% | 3,156B | |
+75.38% | 827B | |
+53.57% | 798B | |
+21.99% | 291B | |
+43.94% | 232B | |
+136.25% | 185B | |
+18.36% | 184B | |
+53.35% | 145B | |
+19.72% | 118B |
- Stock Market
- Equities
- 002104 Stock
- News Hengbao Co.,Ltd.
- Zennova Pharmaceuticals Group announced that it has received CNY 100 million in funding from Hengbao Co.,Ltd.